Prostate Cancer - Results from #2500

Changes in serum PSA after endoscopic enucleation of the prostate are predictive for the future diagnosis of prostate cancer. July 6, 2023

Case Series of Men with the Germline APC I1307K variant and Treatment-Emergent Neuroendocrine Prostate Cancer July 5, 2023

New VA Study to Develop Artificial Intelligence That Can Predict Aggressive Prostate Cancer July 5, 2023

The impact of adding cost information to a conversation aid to support shared decision making about low-risk prostate cancer treatment: Results of a stepped-wedge cluster randomised trial. July 5, 2023

Agent Orange exposure and prostate cancer risk in the Million Veteran Program. July 5, 2023

Niraparib plus abiraterone acetate with prednisone in patients with metastatic castration-resistant prostate cancer and homologous recombination repair gene alterations: second interim analysis of the randomized phase III MAGNITUDE trial. July 5, 2023

Role of FDG PET/CT in Management of Patients with Prostate Cancer. July 5, 2023

Feasibility of home-based exercise training during adjuvant treatment for metastatic castrate-resistant prostate cancer patients treated with an androgen receptor pathway inhibitor (EXACT). July 5, 2023

Prostate cancer screening: well intentioned initiatives may use up resources but not improve health outcomes. July 5, 2023

Palmitoyl acyltransferase ZDHHC7 inhibits androgen receptor and suppresses prostate cancer. July 5, 2023

Association Between Cardiorespiratory Fitness and Cancer Incidence and Cancer-Specific Mortality of Colon, Lung, and Prostate Cancer Among Swedish Men. July 5, 2023

Impact of Clinical History on Maximum PI-RADS Version 2 Score: A Six-Reader 120-Case Sham History Retrospective Evaluation. July 5, 2023

Impact of performance status on efficacy of systemic therapy for prostate cancer: a meta-analysis. July 4, 2023

Does Research from Clinical Trials in Metastatic Hormone-sensitive Prostate Cancer Treatment Translate into Access to Treatments for Patients in the "Real World"? A Systematic Review. July 4, 2023

Targeted Biopsy in Men High Risk for Prostate Cancer: 68Ga-PSMA PET/CT Versus mpMRI. July 4, 2023

Integrative identification of non-coding regulatory regions driving metastatic prostate cancer. July 4, 2023

Dose outside of the prostate is associated with improved outcomes for high-risk prostate cancer patients treated with brachytherapy boost. July 4, 2023

Novel radiomic analysis on bi-parametric MRI for characterizing differences between MR non-visible and visible clinically significant prostate cancer. July 4, 2023

Immunotherapy combinations for metastatic castration-resistant prostate cancer - failed trials and future aspects. July 4, 2023

Outcomes after definitive radiation therapy for localized prostate cancer in a national health care delivery system. July 3, 2023

Page 126 of 1439